We believe in the promise that e-health coupled with molecular science will revolutionize the diagnosis, prevention and treatment of human diseases. Combining digital data with molecular biomarkers allows the integration of both microscopic determinants (e.g. genomic, proteomic, histological, biochemical, etc.) and overall behavioral components for better clinical decisions.
We provide a comprehensive approach of personalized medicine by addressing both digital health and biomarkers issues.
Kyomed’s approach is based on the 4P medical paradigm that is predictive, preventive, personalized, and participatory.